from Global Health Program

A Year Out: Addressing International Impacts of the COVID-19 Pandemic

March 18, 2021

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

In his testimony before the U.S. House of Representatives Committee on Foreign Affairs, Thomas J. Bollyky provides an overview of current engagement of the United States and its allies in addressing the global inequities in vaccine distribution; the emerging circumstances that justify increased U.S. engagement in coronavirus vaccine diplomacy; and a proposal for a U.S.-led initiative to increase the capacity, transparency, and resilience of vaccine manufacturing in order to meet U.S. and global needs.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

Top Stories on CFR

Asia

The partnership India has forged with the United States, Australia, and Japan appears to be gaining momentum, but some challenges remain.

Pharmaceuticals and Vaccines

The swift development of effective vaccines against the new coronavirus was an unprecedented scientific achievement. But production challenges, vaccine nationalism, and new virus strains have all presented hurdles.

Peacekeeping

Africa continues to have more peacekeeping missions than any other continent. As conflict-stricken countries increasingly look outside the United Nations for support, experts say reforms are necessary to improve peacebuilding.